The Defense Innovation Unit has chosen access to Advanced Health Institute and ENA therapeutic to prototype a small molecular nasal spray designed to increase the immunity of US troops against respiratory viruses. Within the scope of the project Panac of the Ministry of Defense, ENA will produce a large spectrum nasal spray with Nipah virus and pandemic influenza in pre -clinical studies. Nasal spray will serve as a prophylaxis for new variants of new viruses and existing respiratory viruses. The 18 -month project was launched in cooperation with DIU and Joint Project Manager under the Modular Progress Program and Vaccine Accelerator. JPEO Joint Product Manager Amanda Love, "Covid-19 PANDEM learned lessons, the biotechnology industry with the application of new technologies, emphasized the need to address viral threats," he said.